tiprankstipranks
Trending News
More News >
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Income Statement

Compare
131 Followers

Dermata Therapeutics Income Statement

Last quarter (Q3 2025), Dermata Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Dermata Therapeutics's net income was $-1.69M. See Dermata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -322.00
Operating Expenses
$ 12.51M$ 8.04M$ 9.67M$ 7.86M$ 3.17M
Depreciation and Amortization
$ 0.00$ 8.04M$ 0.00$ 0.00$ 322.00
EBITDA
$ -12.29M$ 247.22K$ -9.61M$ -7.86M$ -3.04M
Operating Income
$ -12.51M$ -8.04M$ -9.67M$ -7.86M$ -3.17M
Other Income/Expenses
$ 225.78K$ 247.22K$ 63.57K$ -45.61K$ -63.68K
Pretax Income
$ -12.29M$ -7.79M$ -9.61M$ -7.90M$ -3.24M
Net Income
$ -12.29M$ -7.79M$ -9.61M$ -7.90M$ -3.24M
Per Share Metrics
Basic EPS
$ -80.32$ -401.80$ -139.20$ -152.70$ -932.64
Diluted EPS
$ -80.32$ -399.81$ -139.20$ -152.70$ -932.64
Weighted Average Shares Outstanding
153.00K 19.40K 69.07K 52.05K 3.47K
Weighted Average Shares Outstanding (Diluted)
153.00K 19.50K 69.07K 52.05K 3.47K
Currency in USD

Dermata Therapeutics Earnings and Revenue History